Clinical trials · Pennsylvania
Hereditary Angioedema - Type 2 clinical trials in Pennsylvania
We’re tracking 2 recruiting hereditary angioedema - type 2 studies with a site in Pennsylvania — including Phase 3 studies, each written for real people, not researchers.
Recruiting studies in Pennsylvania
- NCT07204938Enrolling by invitationPhase 3
Long-term study of navenibart for hereditary angioedema
This study tests navenibart over a longer period to see if it continues to prevent swelling attacks in people with hereditary angioedema. It is for people who were already in a previous navenibart study.
Hershey, PennsylvaniaAges 12 years+ - NCT06679881RecruitingPhase 3
Preventing swelling attacks with oral deucrictibant for HAE
This study tests a long-term daily pill to prevent swelling attacks in people with hereditary angioedema (HAE). The pill, called deucrictibant, is designed to block a protein involved in causing attacks. It's for adolescents and adults who want to reduce how often swelling episodes occur.
Hershey, PennsylvaniaAges 12 years+
Where these studies are running in Pennsylvania
Institutions with a site for the recruiting hereditary angioedema - type 2 studies listed above.
- Site 9
- Study Site
What taking part in a hereditary angioedema - type 2 study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Hereditary Angioedema - Type 2 trials in other states
Common questions
- Are there hereditary angioedema - type 2 clinical trials in Pennsylvania?
- Yes. We're currently tracking 2 recruiting hereditary angioedema - type 2 studies with a site in Pennsylvania, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a hereditary angioedema - type 2 study in Pennsylvania?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Pennsylvania to take part?
- Not necessarily. These studies have a site in Pennsylvania, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a hereditary angioedema - type 2 trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New hereditary angioedema - type 2 studies open in Pennsylvania regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.